Quan, Bao-Xue
Shuai, Huiping http://orcid.org/0000-0001-8078-4113
Xia, An-Jie http://orcid.org/0000-0002-2695-3024
Hou, Yuxin
Zeng, Rui
Liu, Xin-Lei
Lin, Gui-Feng
Qiao, Jing-Xin
Li, Wen-Pei
Wang, Fa-Lu
Wang, Kai
Zhou, Ren-Jie
Yuen, Terrence Tsz-Tai
Chen, Ming-Xin
Yoon, Chaemin
Wu, Ming
Zhang, Shi-Yu
Huang, Chong
Wang, Yi-Fei
Yang, Wei
Tian, Chenyu
Li, Wei-Min http://orcid.org/0000-0003-0985-0311
Wei, Yu-Quan
Yuen, Kwok-Yung http://orcid.org/0000-0002-2083-1552
Chan, Jasper Fuk-Woo http://orcid.org/0000-0001-6336-6657
Lei, Jian http://orcid.org/0000-0001-9326-0554
Chu, Hin http://orcid.org/0000-0003-2855-9837
Yang, Shengyong http://orcid.org/0000-0001-5147-3746
Article History
Received: 20 January 2022
Accepted: 4 April 2022
First Online: 27 April 2022
Competing interests
: West China Hospital of Sichuan University has applied for a Chinese patent covering Y180 and related compounds in 2021 (application number: 202111494340.0). J.F.-W.C. has received travel grants from Pfizer Corporation Hong Kong and Astellas Pharma Hong Kong Corporation Limited and was an invited speaker for Gilead Sciences Hong Kong Limited and Luminex Corporation. The funding sources had no role in study design, data collection, analysis or interpretation, or the writing of the paper. The other authors declare no competing interests.
Free to read: This content has been made available to all.